Relief Therapeutics Holding AG, a biopharmaceutical company, provides patients with therapeutic relief from serious diseases with high unmet medical need in Switzerland, rest of Europe, North America, and internationally. The company focuses on clinical-stage programs based on molecules with a history of clinical use and either initial human activity or efficacy data or a strong scientific rationale. Its lead compound is RLF-100 (aviptadil), a synthetic human vasoactive intestinal peptide (VIP) with a multifaceted mode of action for respiratory indications, which is in Phase 3 clinical trials for treating COVID-19-induced acute respiratory distress syndrome and moderate to severe COVID-19 lung injury; in Phase 1 clinical trial for the treatment of patients with acute lung injury in other intensive care unit; and in Phase 2 clinical trial for the treatment of pulmonary sarcoidosis. The company is also developing ACER-001, a proprietary powder formulation of sodium phenylbutyrate, which has completed Phase 3 clinical trial for urea cycle disorders; and in Phase 1 clinical trial for the treatment of maple syrup urine disease. In addition, it is developing APR-TD011, a spray-formulated hypotonic acid-oxidizing solution, which is in Phase 2 clinical trial for treating epidermolysis bullosa. The company was founded in 2013 and is based in Geneva, Switzerland. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of RELIEF THERAPEUTICS Holding AG.
RELIEF THERAPEUTICS Holding AG business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of RELIEF THERAPEUTICS Holding AG are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of RELIEF THERAPEUTICS Holding AG , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of RELIEF THERAPEUTICS Holding AG including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of RELIEF THERAPEUTICS Holding AG and all latest updates of the company are provided.
The 2025 version of RELIEF THERAPEUTICS Holding AG report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 RELIEF THERAPEUTICS Holding AG- Key Facts
2.2 RELIEF THERAPEUTICS Holding AG- Geographic Locations
2.3 RELIEF THERAPEUTICS Holding AG- Subsidiaries and Affiliates
2.4 RELIEF THERAPEUTICS Holding AG- Business Divisions
2.5 RELIEF THERAPEUTICS Holding AG- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. RELIEF THERAPEUTICS Holding AG Strategic Analysis Review
3.1 RELIEF THERAPEUTICS Holding AG- Key Strategies
3.2 RELIEF THERAPEUTICS Holding AG- Company Outlook Statement
3.3 RELIEF THERAPEUTICS Holding AG- SWOT Analysis
3.3.1 RELIEF THERAPEUTICS Holding AG- Key Strengths
3.3.2 RELIEF THERAPEUTICS Holding AG- Key Weaknesses
3.3.3 RELIEF THERAPEUTICS Holding AG- Potential Opportunities
3.3.4 RELIEF THERAPEUTICS Holding AG- Potential Threats
3.4 RELIEF THERAPEUTICS Holding AG- Key Competitors
4. Business Description of the Company
4.1 RELIEF THERAPEUTICS Holding AG- Business Overview
4.2 RELIEF THERAPEUTICS Holding AG- Operations by Segment
5 Products and Services Details
5.1 RELIEF THERAPEUTICS Holding AG- Key Products
5.2 RELIEF THERAPEUTICS Holding AG- Key Service Areas
5.3 RELIEF THERAPEUTICS Holding AG- Key Brands
6 Company Developments
6.1 RELIEF THERAPEUTICS Holding AG- Company History
6.2 RELIEF THERAPEUTICS Holding AG- Latest Developments
7 Financial Analysis
7.1 RELIEF THERAPEUTICS Holding AG- Income Statements
7.2 RELIEF THERAPEUTICS Holding AG- Balance Sheet
7.3 RELIEF THERAPEUTICS Holding AG- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 RELIEF THERAPEUTICS Holding AG- Direct Competitors
8.2 RELIEF THERAPEUTICS Holding AG- Competitor Financial Ratios comparison
8.3 RELIEF THERAPEUTICS Holding AG- Competitor Stock Charts Comparison
8.4 RELIEF THERAPEUTICS Holding AG- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
$50- 50%
$100- 15%
$200- 10%
$100- 20%
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!